This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
We identify safer crypto choices for newcomers, covering safety features, liquidity signals, and a starter framework.
18,936 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Oil prices remain a key driver for energy stocks. This article highlights three dividend-friendly picks—Chevron, Exxo...
Sandisk has delivered an extraordinary rally, but can it keep climbing? This guide breaks down what powered the move,...
Dell Technologies slid sharply on a broader AI rotation, yet fundamentals remained solid, prompting Jim Cramer to cal...
Markets can stay calm even when prices rise, but two hidden forces often lurk beneath the surface. This guide identif...
With policy tailwinds and growing demand, the solar sector remains a core focus for 2026. Here are the best solar sto...
Markets have cooled, but big tech still stands out. Here are five names that look unusually affordable, with clear pa...
A majority of Americans fear AI-driven job losses will push the cost and effort of buying a home out of reach, accord...
Oil prices rebounded today, lifting energy stocks. ExxonMobil led gains as the market priced in stronger cash flow, s...
Feeling unsure about Pinterest in your portfolio? This practical guide breaks down how to decide if you should sell P...
As Rex gears up to report Q4 2025 results, investors should focus on growth drivers, margins, and the outlook. This g...
Savvy savers in their 40s are increasingly splitting 401K contributions between traditional and Roth accounts to bala...